Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
Abstract Selective estrogen receptor modulators (SERMs) such as tamoxifen have proven to be effective in the treatment of estrogen receptor (ER) positive breast cancer. However, a major obstacle for such endocrine therapy is estrogen independent growth, leading to resistance, and the underlying mech...
Saved in:
Main Authors: | Wan-Xin Peng, Pratirodh Koirala, Huaixiang Zhou, Jiahong Jiang, Ziqiang Zhang, Liu Yang, Yin-Yuan Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-10-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04288-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
by: Wan-Xin Peng, et al.
Published: (2025-01-01) -
Leuprolide Acetate Treatment for Ovarian Cysts in Breast Cancer Patients Under Tamoxifen Therapy
by: Şafak Yılmaz Baran, et al.
Published: (2022-12-01) -
LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1
by: Hui Yuan, et al.
Published: (2025-01-01) -
Targeting estrogen-regulated system xc − promotes ferroptosis and endocrine sensitivity of ER+ breast cancer
by: Jiawei Cao, et al.
Published: (2025-01-01) -
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer
by: Viola Melone, et al.
Published: (2025-02-01)